Usefulness of 18F-FDG-PET/CT in Evaluating a Brainstem Glioma in an Adult Patient with Neurofibromatosis Type 1

Nuclear Medicine and Molecular Imaging - Tập 47 - Trang 212-213 - 2013
Giorgio Treglia1, Barbara Muoio2, Annemilia Del Ciello3, Francesco Bertagna4
1Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
2School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
3Institute of Radiology, Catholic University of the Sacred Heart, Rome, Italy
4Department of Nuclear Medicine, University of Brescia, Brescia, Italy

Tài liệu tham khảo

Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1–11. Albers AC, Gutmann DH. Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother. 2009;9:535–9. Salmaggi A, Fariselli L, Milanesi I, et al. Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol. 2008;255:171–7. Laigle-Donadey F, Doz F, Delattre JY. Brainstem gliomas in children and adults. Curr Opin Oncol. 2008;20:662–7. Ullrich NJ, Raja AI, Irons MB, et al. Brainstem lesions in neurofibromatosis type 1. Neurosurgery. 2007;61:762–6. Moharir M, London K, Howman-Giles R, et al. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging. 2010;37:1309–17. Roselli F, Pisciotta NM, Aniello MS, et al. Brain F-18 Fluorocholine PET/CT for the assessment of optic pathway glioma in neurofibromatosis-1. Clin Nucl Med. 2010;35:838–9. Treglia G, Taralli S, Bertagna F, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review. Radiol Res Pract. 2012;2012:431029.
Thông tin
Thông tin xuất bản

Nuclear Medicine and Molecular Imaging

Tập 47

212-213

Thông tin tác giả